These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15753771)

  • 21. Glutathione
    Zhou Y; Cao X; Yang Y; Wang J; Yang W; Ben P; Shen L; Cao P; Luo L; Yin Z
    Front Immunol; 2018; 9():268. PubMed ID: 29520271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Δ Sequential Organ Failure Assessment.
    de Azevedo JR; Torres OJ; Beraldi RA; Ribas CA; Malafaia O
    J Crit Care; 2015 Feb; 30(1):219.e9-12. PubMed ID: 25241933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
    Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
    J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
    Czura CJ; Yang H; Tracey KJ
    J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
    Sundén-Cullberg J; Nyström T; Lee ML; Mullins GE; Tokics L; Andersson J; Norrby-Teglund A; Treutiger CJ
    Crit Care Med; 2007 Jun; 35(6):1536-42. PubMed ID: 17452927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effects of Remifentanil on Expression of High Mobility Group Box 1 in Septic Rats.
    Seo KH; Choi JW; Jung HS; Yoo H; Joo JD
    J Korean Med Sci; 2017 Mar; 32(3):542-551. PubMed ID: 28145661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting HMGB1 in the treatment of sepsis.
    Wang H; Ward MF; Sama AE
    Expert Opin Ther Targets; 2014 Mar; 18(3):257-68. PubMed ID: 24392842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune cellular interactions during sepsis and septic injury.
    Jacobs RF; Tabor DR
    Crit Care Clin; 1989 Jan; 5(1):9-26. PubMed ID: 2647228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role for CCR2 and HMGB1 in induction of experimental endotoxic shock.
    Alves JN; Pires KM; Lanzetti M; Barroso MV; Benjamim CF; Costa CA; Resende AC; Santos JC; Ribeiro ML; Porto LC; Valença SS
    Arch Biochem Biophys; 2013 Sep; 537(1):72-81. PubMed ID: 23831508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
    Das UN
    Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock.
    Yoo JW; Lee JR; Jung YK; Choi SH; Son JS; Kang BJ; Park TS; Huh JW; Lim CM; Koh Y; Hong SB
    Korean J Intern Med; 2015 Jul; 30(4):471-7. PubMed ID: 26161013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Updated understanding of high mobility group box 1 protein in sepsis].
    Yao YM; Liu H
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jul; 17(7):385-7. PubMed ID: 16004769
    [No Abstract]   [Full Text] [Related]  

  • 33. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
    Zhang Z; Zhang L; Zhou C; Wu H
    Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High mobility group box 1 as a mediator of endotoxin administration after hemorrhagic shock-primed lung injury.
    Guo F; Shi Y; Xu H; Ding J
    Braz J Med Biol Res; 2009 Sep; 42(9):804-11. PubMed ID: 19649395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of HMGB1 translocation to neuronal nucleus in rat model with septic brain injury.
    Li Y; Li X; Qu Y; Huang J; Zhu T; Zhao F; Li S; Mu D
    Neurosci Lett; 2017 Apr; 645():90-96. PubMed ID: 27889435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy of sepsis.
    Evans TJ; Cohen J
    J Med Microbiol; 1993 Apr; 38(4):237-9. PubMed ID: 8474114
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of Xuebijing injection on high-mobility group box chromosomal protein 1 in septic rats].
    Li YP; Qiao YJ; Wu ZX; Yao YM; Yu Y; Wu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):239-41. PubMed ID: 17448282
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of high mobility group box-1 protein in severe sepsis.
    Sunden-Cullberg J; Norrby-Teglund A; Treutiger CJ
    Curr Opin Infect Dis; 2006 Jun; 19(3):231-6. PubMed ID: 16645483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide and vascular reactivity in sepsis.
    Fernandes D; Assreuy J
    Shock; 2008 Oct; 30 Suppl 1():10-3. PubMed ID: 18704016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality.
    Coffey JC; Wang JH; Kelly R; Romics L; O'Callaghan A; Fiuza C; Redmond HP
    J Leukoc Biol; 2007 Oct; 82(4):906-14. PubMed ID: 17626148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.